- 31.5% of product sales, or $1.7M, was recognized in Q3.
- R&D expenses rose to a healthy $14.59 million, up from $11.6 million last year.
- Cash also rose to $180.7 million, up from $156.09 million last year.
Arena Pharmaceuticals, Rigel Pharmaceuticals and Cytokinetics were among the biotech stock movers in premarket trading on Tuesday.
Here's how to trade six of the most active names on the market today.
Arena Pharmaceuticals, Immunomedics and Aralez Pharmaceuticals were among the biotech stock movers in premarket trading on Wednesday.
Everyone else is doing it.